Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Apr 2024)

Risk Score for Prediction of Dialysis After Transcatheter Aortic Valve Replacement

  • Vincenzo Pasceri,
  • Francesco Pelliccia,
  • Roxana Mehran,
  • George Dangas,
  • Italo Porto,
  • Francesco Radico,
  • Fausto Biancari,
  • Fabrizio D'Ascenzo,
  • Francesco Saia,
  • Giampaolo Luzi,
  • Francesco Bedogni,
  • Ignacio J. Amat Santos,
  • Vincenzo De Marzo,
  • Arnaldo Dimagli,
  • Timo Mäkikallio,
  • Eugenio Stabile,
  • Sara Blasco‐Turrión,
  • Luca Testa,
  • Marco Barbanti,
  • Corrado Tamburino,
  • Franco Fabiocchi,
  • Ahmed Chilmeran,
  • Federico Conrotto,
  • Giuliano Costa,
  • Giulio Stefanini,
  • Carmen Spaccarotella,
  • Andrea Macchione,
  • Michele La Torre,
  • Francesco Bendandi,
  • Tatu Juvonen,
  • Wojciech Wańha,
  • Wojtek Wojakowski,
  • Umberto Benedetto,
  • Ciro Indolfi,
  • David Hildick‐Smith,
  • Marco Zimarino

DOI
https://doi.org/10.1161/JAHA.123.032955
Journal volume & issue
Vol. 13, no. 7

Abstract

Read online

Background Dialysis is a rare but serious complication after transcatheter aortic valve replacement. We analyzed the large multicenter TRITAVI (transfusion requirements in transcatheter aortic valve implantation) registry in order to develop and validate a clinical score assessing this risk. Methods and Results A total of 10 071 consecutive patients were enrolled in 19 European centers. Patients were randomly assigned (2:1) to a derivation and validation cohort. Two scores were developed, 1 including only preprocedural variables (TRITAVIpre) and 1 also including procedural variables (TRITAVIpost). In the 6714 patients of the derivation cohort (age 82±6 years, 48% men), preprocedural factors independently associated with dialysis and included in the TRITAVIpre score were male sex, diabetes, prior coronary artery bypass graft, anemia, nonfemoral access, and creatinine clearance <30 mL/min per m2. Additional independent predictors among procedural features were volume of contrast, need for transfusion, and major vascular complications. Both scores showed a good discrimination power for identifying risk for dialysis with C‐statistic 0.78 for TRITAVIpre and C‐statistic 0.88 for TRITAVIpost score. Need for dialysis increased from the lowest to the highest of 3 risk score groups (from 0.3% to 3.9% for TRITAVIpre score and from 0.1% to 6.2% for TRITAVIpost score). Analysis of the 3357 patients of the validation cohort (age 82±7 years, 48% men) confirmed the good discrimination power of both scores (C‐statistic 0.80 for TRITAVIpre and 0.81 for TRITAVIpost score). Need for dialysis was associated with a significant increase in 1‐year mortality (from 6.9% to 54.4%; P=0.0001). Conclusions A simple preprocedural clinical score can help predict the risk of dialysis after transcatheter aortic valve replacement.

Keywords